Literature DB >> 3579677

The spectrum of depression in multiple sclerosis. An approach for clinical management.

R B Schiffer.   

Abstract

Twenty patients with clinically definite multiple sclerosis who experienced major depressive episodes according to Research Diagnostic Criteria are described. The heterogeneous quality of these depressive episodes is presented by categorizing the episodes according to ten Research Diagnostic Criteria depressive subtypes. Four interpersonal management strategies for such patients that are applicable within a neurologic practice setting are described. The most important feature concerning prognosis for these depressive episodes appears to be the relationship between the depressive episode and the underlying demyelinating disease. When depression occurred in the setting of clinically significant disease activity, the outcome was usually favorable.

Entities:  

Mesh:

Year:  1987        PMID: 3579677     DOI: 10.1001/archneur.1987.00520180020009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Suicide and multiple sclerosis: an epidemiological investigation.

Authors:  E N Stenager; E Stenager; N Koch-Henriksen; H Brønnum-Hansen; K Hyllested; K Jensen; U Bille-Brahe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

2.  Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory?

Authors:  J E Aikens; M A Reinecke; N H Pliskin; J S Fischer; J S Wiebe; L M McCracken; J L Taylor
Journal:  J Behav Med       Date:  1999-04

Review 3.  Managing advanced multiple sclerosis.

Authors:  R W Teasell
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

4.  Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction.

Authors:  E Stenager; L Knudsen; K Jensen
Journal:  Ital J Neurol Sci       Date:  1994-03

5.  Personality traits in women with multiple sclerosis: discrepancy in patient/partner report and disease course.

Authors:  Ralph H B Benedict; Elizabeth L Wahlig; Raluca A Topciu; Jessica Englert; Eben Schwartz; Ben Chapman; Bianca Weinstock-Guttman; Paul R Duberstein
Journal:  J Psychosom Res       Date:  2008-11-22       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.